Biomed-Lublin: Difference between revisions
CSV import |
CSV import |
||
| Line 31: | Line 31: | ||
[[Category:Biotechnology companies of Poland]] | [[Category:Biotechnology companies of Poland]] | ||
[[Category:Pharmaceutical companies established in 1945]] | [[Category:Pharmaceutical companies established in 1945]] | ||
<gallery> | |||
File:Biomed_Lublin_Logo.png|Biomed-Lublin | |||
</gallery> | |||
Latest revision as of 21:28, 20 February 2025
Biomed-Lublin is a pharmaceutical company based in Lublin, Poland. It specializes in the production and distribution of biological drugs, vaccines, and diagnostic reagents. The company's product portfolio includes a wide range of medical products used in oncology, immunology, hematology, and infectious diseases.
History[edit]
Biomed-Lublin was established in 1945, shortly after the end of World War II. The company was initially focused on the production of serum and vaccines to combat infectious diseases. Over the years, Biomed-Lublin has expanded its product portfolio and now offers a wide range of pharmaceutical products.
Products[edit]
Biomed-Lublin's product portfolio includes a variety of biological drugs, vaccines, and diagnostic reagents. Some of the company's most notable products include:
- Onco BCG Vaccine: A vaccine used for the treatment of bladder cancer.
- Venoglobulin: A immunoglobulin preparation used in the treatment of immune deficiencies and certain autoimmune diseases.
- Hepatect CP: A hepatitis B immunoglobulin used for the prevention of hepatitis B virus re-infection in liver transplant patients.
Research and Development[edit]
Biomed-Lublin is actively involved in research and development activities. The company collaborates with various research institutions and universities to develop new drugs and improve existing ones. Current research projects focus on areas such as oncology, immunology, and infectious diseases.
See Also[edit]
References[edit]
<references />
-
Biomed-Lublin
